Transcranial Photobiomodulation With Patients With Parkinson's Disease

Al-Zaytoonah University of Jordan

Status: Completed

Conditions: Parkinson Disease

Treatments: Device: transcranial photobiomodulation; Other: exercises training

Study type: Interventional

Funder types: Other

Identifiers

NCT06729125

PD , LASER

Details and patient eligibility

About

Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease. It is a progressive and disabling disease with significative impact on quality of life. Since it has no cure, available treatment is targeted to improve the symptoms due to a lack of dopamine in the central nervous system. The aim of the study was to see how transcranial photobiomodulation (tPBM) helped patients with Parkinson's disease.

Enrollment: 38 patients

Sex: All

Ages: 50 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• idiopathic PD,
• Hoehn & Yahr stage I-IV,
• independent gait with or without technical assistance
• stable parkinsonian medication for at least a month before the study star.

Exclusion criteria

• comorbidities that affect balance or walking,
• other neurological pathologies besides PD,
• chronic diseases not medically controlled and participation in another physiotherapy program or sport activity during the intervention period or in the month before starting the study

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

38 participants in 2 patient groups

study group

Experimental group

Treatment:

Device: transcranial photobiomodulation

control group

Active Comparator group

Treatment:

Other: exercises training